Home › Funds › CAPITAL MANAGEMENT CORP /VA › ANIK
CAPITAL MANAGEMENT CORP /VA position in ANIK
ANIKA THERAPEUTICS INC · Health Care
CAPITAL MANAGEMENT CORP /VA reported holding 379,436 shares of ANIK (ANIKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 1.12% of its reported portfolio and ranking #35 among its reported holdings. CAPITAL MANAGEMENT CORP /VA has disclosed ANIK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CAPITAL MANAGEMENT CORP /VA's ANIK position evolved
CAPITAL MANAGEMENT CORP /VA first disclosed a stake in ANIK in Q3 2023 at 84,225 shares (US$1.6M). The position peaked in Q1 2024 at 364,025 shares, worth US$9.2M. Across 13 filings, CAPITAL MANAGEMENT CORP /VA increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 379,436 shares valued at US$7.5M — a reduction of -69,038 shares quarter over quarter.. Notable position changes include a 322% increase in Q4 2023 (shares rose 12% over the following quarter), a 35% increase in Q3 2025 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 84.22K | $1.57M | New |
| Q4 2023 | 355.53K | $8.06M | Add |
| Q1 2024 | 364.02K | $9.25M | Add |
| Q2 2024 | 328.62K | $8.32M | Reduce |
| Q3 2024 | 290.35K | $7.17M | Reduce |
| Q4 2024 | 325.55K | $5.36M | Add |
| Q1 2025 | 329.66K | $4.95M | Add |
| Q2 2025 | 408.85K | $4.33M | Add |
| Q3 2025 | 551.25K | $5.18M | Add |
| Q4 2025 | 500.46K | $4.81M | Reduce |
| Q1 2026 | 447.72K | $6.49M | Reduce |
| Q2 2026 | 448.47K | $6.56M | Hold |
| Q3 2026 | 379.44K | $7.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIK and 13F data
ANIK (ANIKA THERAPEUTICS INC) is a Health Care company. 22 other funds we track also report a position in ANIK — the largest reported positions include Caligan Partners LP (US$21.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on CAPITAL MANAGEMENT CORP /VA
FAQ
How long has CAPITAL MANAGEMENT CORP /VA held ANIK?
CAPITAL MANAGEMENT CORP /VA has disclosed ANIK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CAPITAL MANAGEMENT CORP /VA's current position in ANIK?
As of Q3 2026, CAPITAL MANAGEMENT CORP /VA holds 379.44K shares of ANIK (ANIKA THERAPEUTICS INC), valued at $7.46M, representing 1.12% of its reported portfolio and ranking #35.
Has CAPITAL MANAGEMENT CORP /VA been buying or selling ANIK?
In the latest 13F filing (Q3 2026), CAPITAL MANAGEMENT CORP /VA reduced its position in ANIK. The position peaked in Q1 2024 at 364.02K shares.
Which other funds hold ANIK?
Other major institutional holders of ANIK include Caligan Partners LP, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.